These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37598704)

  • 1. Modernizing the design and analysis of prevalence surveys for neglected tropical diseases.
    Diggle PJ; Fronterre C; Gass K; Hundley L; Niles-Robin R; Sampson A; Morice A; Scholte RC
    Philos Trans R Soc Lond B Biol Sci; 2023 Oct; 378(1887):20220276. PubMed ID: 37598704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction to the special issue: challenges and opportunities in the fight against neglected tropical diseases: a decade from the London Declaration on NTDs.
    Forbes K; Basáñez MG; Hollingsworth TD; Anderson RM
    Philos Trans R Soc Lond B Biol Sci; 2023 Oct; 378(1887):20220272. PubMed ID: 37598699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of ivermectin, diethylcarbamazine citrate, and albendazole mass drug administration on the prevalence of scabies and soil-transmitted helminths in school-aged children in three municipalities in Timor-Leste: a before-after assessment.
    Le B; Monteiro MAA; Amaral S; Wand H; Matthews A; Hii SF; Clarke NE; Arkell P; Yan J; Engelman D; Fancourt N; Fernandes JL; Steer A; Kaldor J; Traub R; Francis JR; Nery SV
    Lancet Glob Health; 2023 Jun; 11(6):e924-e932. PubMed ID: 37202027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic filariases and soil-transmitted helminthiases in Sri Lanka: the challenge of eliminating residual pockets of transmission.
    Chandrasena NTGA; Gunaratna IE; Ediriweera D; de Silva NR
    Philos Trans R Soc Lond B Biol Sci; 2023 Oct; 378(1887):20220280. PubMed ID: 37598710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial.
    Hardy M; Samuela J; Kama M; Tuicakau M; Romani L; Whitfeld MJ; King CL; Weil GJ; Grobler AC; Robinson LJ; Kaldor JM; Steer AC
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008106. PubMed ID: 32176703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Thailand eliminated lymphatic filariasis as a public health problem.
    Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
    Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
    Jambulingam P; Kuttiatt VS; Krishnamoorthy K; Subramanian S; Srividya A; Raju HKK; Rahi M; Somani RK; Suryaprakash MK; Dwivedi GP; Weil GJ
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009069. PubMed ID: 33591979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.
    Supali T; Djuardi Y; Christian M; Iskandar E; Alfian R; Maylasari R; Destani Y; Lomiga A; Minggu D; Lew D; Bogus J; Weil GJ; Fischer PU
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009294. PubMed ID: 33780481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis.
    Macfarlane CL; Budhathoki SS; Johnson S; Richardson M; Garner P
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD003753. PubMed ID: 30620051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A positive consequence of the COVID-19 pandemic: how the counterfactual experience of school closures is accelerating a multisectoral response to the treatment of neglected tropical diseases.
    Bundy DAP; Schultz L; Antoninis M; Barry FBM; Burbano C; Croke K; Drake L; Gyapong J; Karutu C; Kihara J; Lo MM; Makkar P; Mwandawiro C; Ossipow SJ; Bento AR; Rollinson D; Shah H; Turner HC
    Philos Trans R Soc Lond B Biol Sci; 2023 Oct; 378(1887):20220282. PubMed ID: 37598709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling morbidity for neglected tropical diseases: the long and winding road from cumulative exposure to long-term pathology.
    Borlase A; Prada JM; Crellen T
    Philos Trans R Soc Lond B Biol Sci; 2023 Oct; 378(1887):20220279. PubMed ID: 37598702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial.
    Laman M; Tavul L; Karl S; Kotty B; Kerry Z; Kumai S; Samuel A; Lorry L; Timinao L; Howard SC; Makita L; John L; Bieb S; Wangi J; Albert JM; Payne M; Weil GJ; Tisch DJ; Bjerum CM; Robinson LJ; King CL
    Lancet Infect Dis; 2022 Aug; 22(8):1200-1209. PubMed ID: 35533701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress Report on Neglected Tropical Disease Drug Donation Programs.
    Cohen JP; Silva L; Cohen A; Awatin J; Sturgeon R
    Clin Ther; 2016 May; 38(5):1193-204. PubMed ID: 27041410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling Neglected Tropical Diseases (NTDs) in Haiti: Implementation Strategies and Evidence of Their Success.
    Lemoine JF; Desormeaux AM; Monestime F; Fayette CR; Desir L; Direny AN; Carciunoiu S; Miller L; Knipes A; Lammie P; Smith P; Stockton M; Trofimovich L; Bhandari K; Reithinger R; Crowley K; Ottesen E; Baker M
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0004954. PubMed ID: 27706162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albendazole for lymphatic filariasis.
    Addiss D; Critchley J; Ejere H; Garner P; Gelband H; Gamble C;
    Cochrane Database Syst Rev; 2004; (1):CD003753. PubMed ID: 14974034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study.
    Dubray CL; Sircar AD; Beau de Rochars VM; Bogus J; Direny AN; Ernest JR; Fayette CR; Goss CW; Hast M; O'Brian K; Pavilus GE; Sabin DF; Wiegand RE; Weil GJ; Lemoine JF
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008298. PubMed ID: 32511226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, feasibility and safety of co-administering azithromycin, albendazole, and ivermectin during mass drug administration: A review.
    McPherson S; Solomon AW; Seife F; Solomon H; Gebre T; Mabey DCW; Marks M
    PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011224. PubMed ID: 37315102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and Analysis of Elimination Surveys for Neglected Tropical Diseases.
    Fronterre C; Amoah B; Giorgi E; Stanton MC; Diggle PJ
    J Infect Dis; 2020 Jun; 221(Suppl 5):S554-S560. PubMed ID: 31930383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress towards control and elimination of neglected tropical diseases targeted by preventive chemotherapy in São Tomé e Príncipe.
    Byrne A; Rosário A; da Conceição Ferreira M; de Jesus Trovoada Dos Santos M; Rollinson D; Vaz Nery S
    Trans R Soc Trop Med Hyg; 2022 May; 116(5):446-453. PubMed ID: 34718820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rethinking neglected tropical disease prevalence survey design and analysis: a geospatial paradigm.
    Diggle PJ; Amoah B; Fronterre C; Giorgi E; Johnson O
    Trans R Soc Trop Med Hyg; 2021 Mar; 115(3):208-210. PubMed ID: 33587142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.